Is Aphria Still the Top Canadian Cannabis Stock?

: APHA | Aphria Inc. Common Shares News, Ratings, and Charts

APHA – Aphria (APHA) has been able to outpace its competitors in terms of revenue and price performance. But, is it still the top Canadian cannabis stock? Read more to learn how APHA’s business model has set it up for long-term success.

A canadian cannabis stock that stands above the rest is Aphria (APHA - Get Rating). Compared to its competitors, Canopy Growth (CGC) and Aurora Cannabis (ACB), APHA already has a track record of success. While CGC and ACB have been struggling to write down goodwill due to high-priced acquisitions, APHA has avoided pricey acquisitions and kept a healthy balance sheet and a substantial amount of cash.

APHA has a strong record of sales growth. Its five-year revenue growth average is 206.2%. This is due to its portfolio of brands such as Aphria, Broken Coast, Solei, RIFF, and Good Supply. In its last reported results, net cannabis revenue was up 81% from the prior quarter. This is due to robust volume growth. The cost per dried gram remained low at CAD 0.88. This led to increased profitability for the company. Its adjusted EBITDA was up 49% from the third quarter, to CAD $8.6 million. APHA is currently the only Canadian cannabis producer that generates positive EBITDA.

Unlike its competitors, which sell consumer packaged goods, APHA focuses on flower and vape products. The company also had an extensive international distribution business, which has primarily driven revenue. APHA has operations in ten countries outside Canada. The company’s German subsidiary, CC Pharma, which it acquired last year, has access to nearly 70% of pharmacies in Germany.

APHA is No. 1 in terms of net revenue across all Canadian cannabis companies and it should continue to be for the foreseeable future.  The company is going after the cannabis derivatives market. Derivatives are products such as edibles, cannabis-infused beverages, concentrates, topicals, and vapes. These were made legal in Canada late last year. Previously, only dried flower and cannabis oil were legal. The derivatives market is potentially more lucrative as margins are better. APHA is already the leading derivatives provider in Ontario.

APHA also has one of the best management teams in the industry with CEO Irwin Simon leading the company. Simon has put an emphasis on core business in the Canadian marketplace. 

Though APHA’s performance year-to-date (YTD) is lackluster, -11%, it is significantly outperforming the ETFMG Alternative Harvest ETF (MJ - Get Rating), which is down more than 33% YTD.  It is currently rated a “Strong Buy” by Wall St. analysts, with an average price target of $7.19, which represents a 53% increase from where it currently trades. 

As you can see, APHA stands atop the Canadian cannabis sector.  If you are a long-term investor, you may want to consider adding this strong cannabis stock to your portfolio.

Disclosure: The author is long APHA.

Want More Great Investing Ideas?

7 Best ETFs for the NEXT Bull Market

Is the Stock Market Correction Over?

Chart of the Day- See the Stocks Ready to Breakout


APHA shares were trading at $4.68 per share on Tuesday afternoon, up $0.03 (+0.65%). Year-to-date, APHA has declined -10.34%, versus a 7.21% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
APHAGet RatingGet RatingGet Rating
MJGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Investors Remain “Cautiously Optimistic”

The S&P 500 (SPY) has made great advances since the lows of early April. Yet seem to be stuck under resistance at 6,000. What happens next depends on tariff talks. So let’s talk about the latest news on that front.

Bull Market Til Proven Otherwise

The phrase that paid for investors in 2025 was “Bull market til proven otherwise” Steve Reitmeister explains why in his latest market update and preview of top stock picks.

Investor Alert: Mission Accomplished?

The S&P 500 (SPY) has broken out above the 200 day moving average. Does that mean that bear market fears are now over? And should investors be riding the bull to new heights? Read on for Steve Reitmeister’s answer...

Stock Market Update: It’s Complicated!

The S&P 500 (SPY) may have bounced 17% from recent lows, but the outlook for stocks from here is...in a word...COMPLICATED. Read on to get Steve Reitmeister full market outlook and trading plan for this complicated market environment.

Becoming More Bullish on Stocks, But...

Stocks are on a roll with the S&P 500 (SPY) up more than 10% from the recent lows. Before you start getting too giddy, you should read this updated market outlook and trading plan Steve Reitmeister.

Read More Stories

More Aphria Inc. Common Shares (APHA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All APHA News